{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:35:05Z","timestamp":1793867705750,"version":"4.6.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01 HL129179"],"award-info":[{"award-number":["5R01 HL129179"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.biomaterials.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T01:15:34Z","timestamp":1489454134000},"page":"94-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"special_numbering":"C","title":["Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis"],"prefix":"10.1016","volume":"128","author":[{"given":"Christa L.","family":"Pawlowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaShawn","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurbani","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Sen Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2017.03.012_bib1","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142016 update. A report from the American Heart Association","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrcardio.2011.91","article-title":"Arterial thrombus formation in cardiovascular disease","volume":"8","author":"Lippi","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib4","doi-asserted-by":"crossref","first-page":"33B","DOI":"10.1016\/S0735-1097(86)80005-5","article-title":"Pharmacology of thrombolytic drugs","volume":"8","author":"Verstraete","year":"1986","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib5","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1941875211408731","article-title":"Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies","volume":"1","author":"Miller","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib7","doi-asserted-by":"crossref","DOI":"10.1517\/14728222.12.2.159","article-title":"tPA as a therapeutic target in stroke","volume":"12","author":"Gravanis","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MOH.0b013e32833e77ee","article-title":"Clinical relevance of microparticles from platelets and megakaryocytes","volume":"17","author":"Italiano","year":"2010","journal-title":"Curr. Opin. Haematol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molmed.2004.02.008","article-title":"Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation","volume":"10","author":"Furie","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib11","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCRESAHA.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Owens","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1021\/pr0500760","article-title":"The platelet microparticle proteome","volume":"4","author":"Garcia","year":"2005","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib13","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","article-title":"Platelets in atherothrombosis","volume":"8","author":"Ruggeri","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib14","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1073\/pnas.82.23.8057","article-title":"The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets","volume":"82","author":"Plow","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib15","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1074\/jbc.M209267200","article-title":"Rational optimization of a short human P-selectin binding peptide leads to nanomolar affinity antagonists","volume":"278","author":"Appeldoorn","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib16","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1194\/jlr.R800033-JLR200","article-title":"Phospholipase A2 structure\/function, mechanism, and signaling","volume":"50","author":"Burke","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib17","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1016\/j.ijcard.2013.07.154","article-title":"Phospholipase A2 expression in coronary thrombus is increased in patients with recurrent cardiac events after acute myocardial infarction","volume":"168","author":"Takahashi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib18","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/jps.22530","article-title":"Secretory phospholipase A2 responsive liposomes","volume":"100","author":"Zhu","year":"2011","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib19","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1002\/anie.200900111","article-title":"Disterolphospholipids: non-exchangeable lipids and their application to liposomal drug delivery","volume":"48","author":"Huang","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/09537104.2011.630848","article-title":"Measurement of whole blood thrombus formation using parallel-plate flow chambers \u2013 a practical guide","volume":"23","author":"van Kruchten","year":"2012","journal-title":"Platelets"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib21","doi-asserted-by":"crossref","first-page":"e0125508","DOI":"10.1371\/journal.pone.0125508","article-title":"Development of a cell-based bioassay for phospholipase A2-triggered liposomal drug release","volume":"10","author":"Arouri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib22","first-page":"e54479","article-title":"Ferric chloride induced murine thrombosis models","volume":"115","author":"Li","year":"2016","journal-title":"J.\u00a0Vis. Exp."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/ATVBAHA.111.225334","article-title":"In\u00a0vivo fluorescence imaging of large vessel thrombosis in mice","volume":"31","author":"Cooley","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0038-1656010","article-title":"Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease","volume":"77","author":"Turecek","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib25","first-page":"297","article-title":"Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential","volume":"1","author":"Immordino","year":"2006","journal-title":"Int. J. Nanomed"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/cpt.33","article-title":"Recombinant tissue plasminogen activators (rtPA): a review","volume":"97","author":"Gurman","year":"2015","journal-title":"Clin. Pharmcol. Ther."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An International randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"GUSTO Investigators","year":"1993","journal-title":"NEJM"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1747-4949.2012.00923.x","article-title":"Thrombolysis in the developing world: is there a role for Streptokinase?","volume":"8","author":"Butcher","year":"2013","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib29","first-page":"CD000213","article-title":"Thrombolysis for acute ischemic stroke","volume":"4","author":"Wardlaw","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF02975283","article-title":"Prolonged systemic delivery of streptokinase using liposome","volume":"21","author":"Kim","year":"1998","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1055\/s-0037-1613600","article-title":"Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase","volume":"90","author":"Leach","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1161\/01.CIR.84.2.805","article-title":"Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation","volume":"84","author":"Bode","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib33","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood-2007-07-103002","article-title":"Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/CIRCRESAHA.114.302514","article-title":"Towards effective and safe Thrombolysis and Thromboprophylaxis. Preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets","volume":"114","author":"Wang","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI81470","article-title":"A\u00a0chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation","volume":"126","author":"Fuentes","year":"2016","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib36","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1161\/STROKEAHA.110.598656","article-title":"Rationale for a nanomedicine approach to thrombolytic therapy","volume":"41","author":"Lanza","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib37","first-page":"48","article-title":"Novel and emerging therapies: thrombus-targeted fibrinolysis","volume":"39","author":"Lippi","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2013-03-453498","article-title":"Advanced drug delivery systems for antithrombotic agents","volume":"122","author":"Greineder","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib39","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/jth.13033","article-title":"Engineering of plasminogen activators for targeting to thrombus and heightening thrombolytic efficacy","volume":"13","author":"Absar","year":"2015","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib40","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2217\/17435889.2.4.533","article-title":"Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis","volume":"2","author":"Marsh","year":"2007","journal-title":"Nanomed. (Lond)"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib42","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1002\/adma.201502243","article-title":"Multifunctional thrombin-activatable polymer capsules for specific targeting to activated platelets","volume":"27","author":"Gunawan","year":"2015","journal-title":"Adv. Mater"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt846","article-title":"Prophylactic fibrinolysis through selective dissolution of nascent clots by tPA-carrying erythrocytes","volume":"21","author":"Murciano","year":"2003","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib44","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1021\/nn5029955","article-title":"Acceleration of tissue plasminogen activator-mediated thrombolysis by magnetically powered nanomotors","volume":"8","author":"Cheng","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib45","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/jth.12321","article-title":"Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in\u00a0vitro and in\u00a0vivo study","volume":"11","author":"Hagisawa","year":"2013","journal-title":"J.\u00a0Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11239-014-1071-8","article-title":"In\u00a0vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model","volume":"38","author":"Hua","year":"2014","journal-title":"J.\u00a0Thromb. Thrombolysis"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib47","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7150\/thno.14514","article-title":"Thrombus-targeted theranostic microbubbles: a new technology towards concurrent rapid ultrasound diagnosis and bleeding-free fibrinolytic treatment of thrombosis","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1160\/TH04-06-0340","article-title":"RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system","volume":"93","author":"Sen Gupta","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib49","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1016\/j.biomaterials.2011.08.067","article-title":"Heteromultivalent liposomal nanoconstructs for enhanced targeting and shear-stable binding to active platelets for site-selective vascular drug delivery","volume":"32","author":"Modery","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib50","doi-asserted-by":"crossref","first-page":"11243","DOI":"10.1021\/nn503732m","article-title":"Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries","volume":"8","author":"Anselmo","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib51","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ejps.2011.10.004","article-title":"Platelets directed liposomes for the delivery of streptokinase: development and characterization","volume":"44","author":"Vaidya","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib52","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","article-title":"RGD and other recognition sequences for integrins","volume":"12","author":"Ruoslahti","year":"1996","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib53","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1242\/jcs.03098","article-title":"Integrin ligands at a glance","volume":"119","author":"Humphries","year":"2006","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib54","doi-asserted-by":"crossref","first-page":"39805","DOI":"10.1038\/srep39805","article-title":"A\u00a0comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins","volume":"7","author":"Kapp","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0039-6028(01)01309-7","article-title":"Force measurements on the molecular interaction between ligand (RGD) and human platelet \u03b1IIb\u03b23 receptor system","volume":"491","author":"Lee","year":"2001","journal-title":"Surf. Sci."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0304-3991(03)00059-7","article-title":"Molecular interaction studies of hemostasis: fibrinogen ligand\u2013human platelet receptor interactions","volume":"97","author":"Lee","year":"2003","journal-title":"Ultramicroscopy"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib57","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.biomaterials.2007.12.015","article-title":"Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets","volume":"29","author":"Huang","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1039\/C2PY20576A","article-title":"Reversible maleimide\u2013thiol adducts yield glutathione-sensitive poly(ethylene glycol)\u2013heparin hydrogels","volume":"4","author":"Baldwin","year":"2013","journal-title":"Polym. Chem."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.xphs.2015.11.037","article-title":"Physical and chemical stability of antibody-drug conjugates: current status","volume":"105","author":"Ross","year":"2016","journal-title":"J.\u00a0Pharm. Sci."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib60","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.RES.66.3.875","article-title":"Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase","volume":"66","author":"Nguyen","year":"1990","journal-title":"Circ. Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib61","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1055\/s-0038-1656133","article-title":"Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model","volume":"77","author":"Perkins","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib62","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s12272-015-0594-7","article-title":"Comparative effects of PEG-containing liposomal formulations on in\u00a0vivo pharmacokinetics of streptokinase","volume":"38","author":"Jin","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib63","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3109\/10717544.2014.916770","article-title":"Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in\u00a0vitro\/in\u00a0vivo studies","volume":"23","author":"Vaidya","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib64","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0885328210374778","article-title":"Streptokinase loading in liposomes for vascular targeted nanomedicine applications: encapsulation efficiency and effects of processing","volume":"26","author":"Holt","year":"2012","journal-title":"J.\u00a0Biomater. Appl."},{"key":"10.1016\/j.biomaterials.2017.03.012_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib66","doi-asserted-by":"crossref","first-page":"7043","DOI":"10.1002\/adma.201503323","article-title":"Anti-cancer platelet-mimicking nanovehicles","volume":"27","author":"Hu","year":"2015","journal-title":"Adv. Mater"},{"key":"10.1016\/j.biomaterials.2017.03.012_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2015.10.046","article-title":"Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles","volume":"76","author":"Li","year":"2016","journal-title":"Biomaterials"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217301540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961217301540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:25:26Z","timestamp":1758903926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961217301540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":67,"alternative-id":["S0142961217301540"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.012","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}